Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

Previous trials of adjuvant chemotherapy for oesophagogastric cancer have shown only modest or no improvement in survival. However, the regimens used in these studies produce low response rates in patients with advanced disease. ECF is a new regimen which results in higher response rates and may the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bamias, A., Cunningham, D., Nicolson, V., Norman, A., Hill, M., Nicolson, M., O'Brien, M., Webb, A., Hill, A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1995
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033623/
https://ncbi.nlm.nih.gov/pubmed/7880742
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky